Development of an active-site titrant for SARS-CoV-2 main protease as an indispensable tool for evaluating enzyme kinetics-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Development of an active-site titrant for SARS-CoV-2 main protease as an indispensable tool for evaluating enzyme kinetics

Published:2024-05 Issue:5 Volume:14 Page:2349-2357
ISSN:2211-3835
Container-title:Acta Pharmaceutica Sinica B
language:en
Short-container-title:Acta Pharmaceutica Sinica B

Author:

Voget Rabea^ORCID,Breidenbach Julian,Claff Tobias^ORCID,Hingst Alexandra^ORCID,Sylvester Katharina,Steinebach Christian^ORCID,Vu Lan Phuong,Weiße Renato H.^ORCID,Bartz Ulrike,Sträter Norbert^ORCID,Müller Christa E.^ORCID,Gütschow Michael^ORCID

Funder

Deutsche Forschungsgemeinschaft

Helmholtz Association

European Molecular Biology Laboratory

Volkswagen Foundation

Publisher

Elsevier BV

Reference49 articles.

1. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding;Lu;Lancet,2020

2. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor;Hoffmann;Cell,2020

3. Coronavirus biology and replication: implications for SARS-CoV-2;V’kovski;Nat Rev Microbiol,2021

4. Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors;Zhang;Science,2020

5. The SARS-CoV-2 main protease (Mpro): structure, function, and emerging therapies for COVID-19;Hu;MedComm,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP